Document Detail


Abciximab treatment modalities for thromboembolic events related to aneurysm coiling.
MedLine Citation:
PMID:  21099579     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Thromboembolic complications are the most common cause of periprocedural morbidity associated with the endovascular treatment of intracranial aneurysms with detachable coils.
OBJECTIVE: To estimate the safety and efficacy of using combined intra-arterial and intravenous abciximab to treat thrombi complicating endovascular cerebral aneurysm coil embolization.
METHODS: In a retrospective analysis of 390 aneurysmal coiling procedures, we identified 39 patients (10.0%) with thromboembolic events related to the procedure. As the first line of treatment in 23 of these patients, abciximab was administered intra-arterially as a bolus followed by intravenous infusion over a 12-hour period. Eleven of the 23 patients were treated for ruptured aneurysms, 9 for unruptured aneurysms, and 3 for aneurysmal recanalization. Flow restoration and neurological outcome were evaluated.
RESULTS: Amelioration as measured by the Thrombolysis in Myocardial Infarction flow grade score was achieved in 17 of 23 patients (73.9%), and no change was observed in 6 of 23 patients (26.1%). Complete recanalization was achieved in 13 patients (56.5%). A greater response to abciximab was noted for thrombi at the coil-parent artery interface, and a lesser response was noted for distal thrombi. No hemorrhagic complications were noted for any of the patients, whereas 11 patients (47.8%) showed ischemic lesions. A modified Rankin Scale score of 2 or less was achieved in 17 of 23 patients (73.9%), whereas 6 of 23 patients (26.1%) had a modified Rankin Scale score of more than 2.
CONCLUSION: Combined intra-arterial/intravenous administration of abciximab is safe and effective for treating thromboembolic complications that occur during aneurysmal coil embolization with no hemorrhagic complications.
Authors:
Mohamed Aggour; Laurent Pierot; Krisztof Kadziolka; Philippe Gomis; Jean-Pierre Graftieaux
Related Documents :
9633959 - Iliofemoral venous thrombosis caused by compression of an internal iliac artery aneurys...
12925259 - Basic fibroblast growth factor released from a platinum coil with a polyvinyl alcohol c...
20453659 - Bleeding gastric ulcer after prophylactic coiling of transarterial chemoembolization.
11688709 - Guglielmi detachable coil embolization for ruptured lower-midbasilar trunk aneurysms--a...
11411259 - Aneurysms of the fenestrated basilar artery treated with gulielmi detachabe coils: case...
1198629 - Kinks, coils, and carotids: a review.
12712019 - Transesophageal echocardiography follow-up of patients undergoing replacement of the as...
6528279 - Oesophageal obstruction due to saccular aneurysm of the distal thoracic aorta.
17888969 - Risk factors for perioperative stroke after thoracic endovascular aortic repair.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurosurgery     Volume:  67     ISSN:  1524-4040     ISO Abbreviation:  Neurosurgery     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-11-01     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  7802914     Medline TA:  Neurosurgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  503-8     Citation Subset:  IM    
Affiliation:
Neuroradiology Department, Hopital Maison Blanche, CHU Reims, Reims, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antibodies, Monoclonal / administration & dosage*
Blood Vessel Prosthesis Implantation / adverse effects*,  instrumentation,  methods
Embolization, Therapeutic / adverse effects*,  instrumentation,  methods
Female
Humans
Immunoglobulin Fab Fragments / administration & dosage*
Intracranial Aneurysm / complications,  therapy*
Male
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage*
Retrospective Studies
Thromboembolism / drug therapy*,  etiology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunoglobulin Fab Fragments; 0/Platelet Aggregation Inhibitors; X85G7936GV/abciximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Retrograde trans-posterior communicating artery snare-assisted rescue of lost access to a foreshorte...
Next Document:  Petrous bone pneumatization is a risk factor for cerebrospinal fluid fistula following vestibular sc...